Dermal Filler Market Size & Share, by Materials (Calcium Hydroxylapatite, Hyaluronic Acid, Poly-L-lactic Acid, PMMA, Fat}; Product (Biodegradable, Non-Biodegradable); Application (Lip Enhancement, Wrinkle Correction Treatment, Face-Lift, Scar Treatment) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 2275
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Dermal Filler Landscape

    • Allergen
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Merz Pharma
    • Sinclair Pharma
    • Galderma Laboratories
    • BioPlus Co., Ltd.
    • Candela Corporation
    • BIOXIS pharmaceuticals
    • Suneva Medical
    • SCULPT Luxury Dermal Fillers Ltd
    • Dr. Korman Laboratories Ltd.

Browse Key Market Insights with Data Illustration:


In The News

  • Galderma Laboratories - with an updated administration protocol, announced the re-launch of the injectable poly-L-lactic acid product Sculptra (injectable poly-L-lactic acid) in Europe.

  • Sinclair Company - has signed an exclusive worldwide licensing agreement for a new series of injectable hyaluronic acid treatments.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 2275
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising adoption of cosmetics procedures along with increasing disposable income are the major factors driving the growth of the dermal filler market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.

High cost associated with dermal filler procedures are expected to hinder the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Allergan, Merz Pharma, Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by materials, product, application, and by region.

The calcium hydroxylapatite segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying